Your weekly roundup of the latest news from Drug Topics®.
Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.
Following certification, brick-and-mortar pharmacies will be able to provide the medication to patients.
Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.
Researchers speculate that the disparities among those with private insurance coverage may reflect differences in overcoming hurdles to access, such as prior authorization.
The COVID-19 pandemic revealed the advantages of treatment that involved fewer in-person office visits, according to recent research.